The Drug Discovery and Development (D3) course is a first-of-its kind collaboration between the Novartis Institutes for BioMedical Research (NIBR) and Fast Forward Medical Innovation, a unit of the U-M Medical School Office of Research.
U-M is the first academic institution to host the NIBR D3 course and provide expert drug development education and training for its faculty members.
Course Dates for 2020 Coming Soon!
The D3 Course is a 2-day exclusive, project-based, and simulated approach to teaching drug discovery and development. Participants will be assigned roles on a project team and tasked with the discovery and development of a new medicine. Throughout the course, participants will encounter and make decisions about various scientific challenges, including choosing a therapeutic area and drug target, searching for potential chemical leads, optimizing and progressing those leads through preclinical research, demonstrating that the resulting drug candidate is safe and effective in patients, advancing the drug through subsequent clinical trials, and submitting the drug for registration with the health authorities.